OneTwo Analytics and Endocrine Associates of West Village announce commercial partnership

Jun 5, 2026

STOCKHOLM, Sweden & NEW YORK, NY – June 5th, 2026 - OneTwo Analytics AB (OTA), the Swedish MedTech company behind the AI-powered diabetes management clinician platform today announced a pioneering commercial partnership with Endocrine Associate of West Village, P.C. (EAWV), one of New York City’s leading endocrinology practices. Under the agreement, EAWV becomes OTA’s East Coast Flagship Clinic and the first New York specialist endocrinology group to roll out the OneTwo Analytics platform across its three clinical sites.

The announcement comes ahead of the American Diabetes Association 86th Scientific Sessions, taking place in New Orleans in June 2026, where OTA and EAWV clinicians will engage with the broader diabetes community on what care looks like in everyday practice powered by OneTwo Analytics.

From overload to precision care

Fourteen days of CGM alone generates more than 4,000 individual data points per patient. For specialist clinics managing hundreds to thousands of patients, that volume is increasingly difficult to translate into timely, personalised treatment decisions, a problem that grows as CGM adoption expands across Type 1, Type 2 and pre-diabetic populations. Moreover the complex challenges that arise when taking into consideration the data complexities of insulin pump, AID and connected pen data for these patients.

OneTwo Analytics’ platform uses clinically validated AI and machine learning to convert that raw data into prioritised, actionable insights. Prio™ standardises follow-up scheduling through a clinically validated patient scoring system, while Insights™ surfaces driver-level patterns across glycaemic events, excursions and meal and insulin responses, supporting faster, more confident clinical decisions.

More than just data aggregation, for EAWV, the platform integrates directly with the practice’s existing electronic health record (EHR) and becomes a workflow optimisation engine. On top of this the platform includes a smart detection of billable events and automates the billing process, to remove additional administrative burden and help to maximise a clinics P&L optimisation.

A flagship partnership for the US market

EAWV operates three clinics in New York City and serves a substantial diabetes population across Type 1, Type 2 and complex endocrine cases. As OTA’s East Coast Flagship Clinic, EAWV will collaborate on real-world performance and help shape the product roadmap for US specialist practice.

The partnership reflects a shared conviction: that in healthcare, the most valuable contribution is giving clinicians back their time and attention, rather than adding another screen to monitor. Since the OTA platform was built by clinicians for clinicians, the core belief is to allow healthcare practitioners focus on delivering care.

What the partners are saying

“EAWV is exactly the kind of partner we set out to find in the US market. A clinically respected, forward-looking endocrinology group that takes the experience of both the clinician and the patient seriously,” said Lars Cederblad, CEO and Co-founder of OneTwo Analytics. “As our pioneering East Coast partner this now accelerates our US strategy meaningfully. Together we’re demonstrating that AI in diabetes care isn’t about replacing clinical judgement, it’s about giving clinicians the clarity to apply it.

“Our clinicians are managing more CGM data than any human can reasonably synthesise in a fifteen-minute consultation,” said Dr. Anastasios Manessis, Endocrine Associates of West Village. “What drew us to OneTwo Analytics is that the platform doesn’t replace the clinical conversation, it prepares us for it. We walk into the room already knowing what matters most for that patient, that day.”

“Just as importantly, the workflow integration with our EHR and billing systems means our team spends less time on administration and more time delivering care. That’s a meaningful change for a specialist practice operating at our volume, and it’s why we’re proud to be OneTwo Analytics’ East Coast Flagship Clinic.”

What this means for patients

For patients of EAWV, the partnership translates into more focused consultations, faster identification of glucose patterns that warrant attention, and a treatment plan that reflects the full picture of their data rather than a snapshot. Patient onboarding to the platform is structured in phases over the partnership rollout.

Looking ahead to ADA 2026

Representatives from OneTwo Analytics will be available at the ADA 86th Scientific Sessions (Booth #918) in New Orleans to discuss the partnership, demonstrate the platform, and share early operational insights from the deployment. Meeting requests can be made via the media contacts below.

About OneTwo Analytics

OneTwo Analytics AB is a Swedish MedTech company founded in 2019 with a mission to transform diabetes and pre-diabetes management through AI and machine learning. The company’s platform, comprising Prio™ and Insights™ translates large datasets into clinically validated metrics and actionable insights, enabling specialist clinics and primary care providers to deliver scalable, value-based diabetes care. The OneTwo Analytics SaMD are FDA-listed and CE-marked and the platform integrates into existing EHR systems.

About Endocrine Associate of West Village, P.C.

Endocrine Associate of West Village, P.C. (EAWV) is a leading New York City endocrinology practice operating across three clinical sites. EAWV provides comprehensive specialist care across diabetes, thyroid, metabolic and broader endocrine conditions, with a particular focus on combining clinical excellence with a patient-centred experience. As OneTwo Analytics’ East Coast Flagship Clinic, EAWV is helping to define how AI-assisted diabetes care is delivered in US specialist practice.